Your browser doesn't support javascript.
loading
HSP90 inhibitor RGRN-305 for oral treatment of plaque-type psoriasis: efficacy, safety and biomarker results in an open-label proof-of-concept study.
Bregnhøj, A; Thuesen, K K H; Emmanuel, T; Litman, T; Grek, C L; Ghatnekar, G S; Johansen, C; Iversen, L.
Afiliação
  • Bregnhøj A; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Thuesen KKH; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Emmanuel T; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Litman T; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, 2200, Denmark.
  • Grek CL; FirstString Research, Mount Pleasant, SC, 29464, USA.
  • Ghatnekar GS; Regranion, Mount Pleasant, SC, 29464, USA.
  • Johansen C; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Iversen L; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Br J Dermatol ; 186(5): 861-874, 2022 05.
Article em En | MEDLINE | ID: mdl-34748646
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article